Instituto de Patobiología, Instituto Nacional de Tecnología Agropecuaria-INTA, Nicolás Repetto y De los Reseros, 1686 Hurlingham, Buenos Aires, Argentina.
J Dairy Sci. 2012 Jun;95(6):3318-26. doi: 10.3168/jds.2011-5093.
Enterohemorrhagic Escherichia coli (EHEC) O157:H7 is a major cause of intestinal disease and hemolytic uremic syndrome, a serious systemic complication that particularly affects children. Cattle are primary reservoirs for EHEC O157:H7 and the main source of infection for humans. Vaccination of cattle with different combinations of bacterial virulence factors has shown efficacy in decreasing EHEC O157:H7 shedding. It is, therefore, important to demonstrate whether vaccination of pregnant cows with EHEC O157:H7 induces high titers of transferable antibodies to avoid early colonization of calves by the bacteria. In this study we evaluated the ability of EspA, EspB, the C-terminal fragment of 280 amino acids of γ-intimin (γ-intimin C₂₈₀) and inactivated Shiga toxin (Stx) 2 proteins to induce specific antibodies in colostrum and their passive transference to colostrum-fed calves. Friesian pregnant cows immunized by the intramuscular route mounted significantly high serum and colostrum IgG responses against EspB and γ-intimin C₂₈₀ that were efficiently transferred to their calves. Antibodies to EspB and γ-intimin C₂₈₀ were detected in milk samples of vaccinated cows at d 40 postparturition. Significant Stx2-neutralizing titers were also observed in colostrum from Stx2-vaccinated cows and sera from colostrum-fed calves. The results presented showed that bovine colostrum with increased levels of antibodies against EHEC O157:H7 may be obtained by systemic immunization of pregnant cows, and that these specific antibodies are efficiently transferred to newborn calves by feeding colostrum. Hyperimmune colostrum and milk may be an alternative to protect calves from early colonization by EHEC O157:H7 and a possible key source of antibodies to block colonization and toxic activity of this bacterium.
肠出血性大肠杆菌(EHEC)O157:H7 是肠道疾病和溶血性尿毒综合征的主要病因,这是一种严重的全身性并发症,尤其会影响儿童。牛是 EHEC O157:H7 的主要宿主,也是人类感染的主要来源。用不同组合的细菌毒力因子对牛进行疫苗接种已证明能有效减少 EHEC O157:H7 的脱落。因此,重要的是要证明用 EHEC O157:H7 对怀孕的母牛进行疫苗接种是否能诱导出高滴度的可转移抗体,以避免细菌对小牛的早期定植。在这项研究中,我们评估了 EspA、EspB、γ-肠凝聚素(γ-intimin C₂₈₀)的 C 末端 280 个氨基酸片段和失活的志贺毒素(Stx)2 蛋白在诱导初乳中特异性抗体及其被动转移到初乳喂养的小牛中的能力。通过肌肉途径免疫的弗里西亚怀孕奶牛对 EspB 和 γ-intimin C₂₈₀产生了显著高的血清和初乳 IgG 反应,这些反应有效地转移到了它们的小牛身上。在产后第 40 天,接种疫苗的奶牛的牛奶样本中检测到针对 EspB 和 γ-intimin C₂₈₀ 的抗体。在接种 Stx2 的奶牛的初乳和初乳喂养的小牛的血清中也观察到了显著的 Stx2 中和滴度。所呈现的结果表明,通过对怀孕奶牛进行全身免疫,可以获得含有针对 EHEC O157:H7 的抗体水平增加的牛初乳,并且这些特异性抗体可以通过喂养初乳有效地转移到新生小牛身上。高免疫初乳和牛奶可能是保护小牛免受 EHEC O157:H7 早期定植的一种替代方法,也是阻止这种细菌定植和毒性活性的抗体的一个潜在重要来源。